STAA (STAAR Surgical Corp) Gross Profit Margin

STAA (STAAR Surgical Corp) - company brandmark

STAAR Surgical Company (STAA) has created a closed ophthalmological system where physician training and contract exclusivity hinder customer churn to competitors. Gross margins illustrate the efficiency of this model, and 71.30 reflects the latest value of this metric. The rise in myopia and the expansion of EVO ICL lenses in China and the US are driving the business, while the global implementation of innovations ensures the current financial result.

STAA - STAAR Surgical Co Return on Gross Profit over the range 07/04/2022 - 11/20/2026

Analytical breakdowns and data insights for company staar.com (STAA)

Summary company analysis:STAAR Surgical - STAA
Mass-produced product of STAAR Surgical Company

Gross margin determines the portion of revenue remaining after covering direct production costs, allowing for an assessment of cost management efficiency and the product's pricing power. By analyzing the gross profit margin chart, investors evaluate the stability of STAAR Surgical Company (STAA), considering how outsourcing lens manufacturing and logistics to third-party contractors impacts the business's overall operational efficiency.

Direct competitors